Start for free
Start for free
AC

Apothecary Capital

North America, Illinois, United States, Chicago

Description

Apothecary Capital is an Illinois-based venture capital firm that provides financial advisory services.

Investor Profile

Apothecary Capital has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series C (60%)
  • Series Unknown (20%)
  • Series D (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apothecary Capital frequently co-invest with?

Goldman Sachs
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 2
Altitude Life Science Ventures
Altitude Life Science Ventures
North America, Colorado, United States, Durango
Co-Investments: 1
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Versant Ventures
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
T. Rowe Price
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
MB
Merlin Biomed
North America, New York, United States, New York
Co-Investments: 2
Frazier Healthcare Partners
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Prospect Venture Partners
Prospect Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 3
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Brookside Capital
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Apothecary Capital?

Portola Pharmaceuticals

South San Francisco, California, United States

Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.

BiopharmaBiotechnologyTherapeutics
Series CJul 1, 2008
Amount Raised: $60,099,999
Kythera Biopharmaceuticals

Calabasas, California, United States

Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.

BiopharmaBiotechnologyHealth Care
Series CMay 19, 2008
Amount Raised: $30,000,000
Cogentus Pharmaceuticals

Menlo Park, California, United States

Cogentus Pharmaceuticals is a company focused on developing prescription pharmaceutical products in North America and Europe.

BiotechnologyMedicalPharmaceutical
Series CDec 21, 2007
Amount Raised: $62,500,000
Calypso Medical

Seattle, Washington, United States

Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.

Health CareMedicalMedical Device
Series DJan 8, 2007
Amount Raised: $42,200,000
FibroGen

San Francisco, California, United States

FibroGen uses its expertise in CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownFeb 17, 2005
Amount Raised: $100,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator